A controlled clinical trial comparing potent progestins, LNG-IUS and dienogest, for the treatment of women with adenomyosis.

Ikuko OtaFuminori TaniguchiYoshiaki OtaHiroki NagataIkumi WadaTakaya NakasoAi IkebuchiEri SatoYukihiro AzumaTasuku Harada

Published in: Reproductive medicine and biology (2021)

LNG-IUS and DNG could be useful for long-term management of adenomyosis. In terms of durations of uterine bleeding, DNG was superior to LNG-IUS for 6 years.

Keyphrases

clinical trial
atrial fibrillation
study protocol
randomized controlled trial
anti inflammatory
double blind
combination therapy
replacement therapy